Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ningbin Wu"'
Autor:
Zhao Wang1, Ningbin Wu1, Tesfaye, Abeba2, Feinstone, Stephen1,2, Kumar, Ajit1,3 akumar@gwu.edu
Publikováno v:
Infectious Agents & Cancer. Jul2015, Vol. 10 Issue 1, p1-9. 9p. 1 Chart, 5 Graphs.
Autor:
Jian Jin, Ziyu Wang, Long Wan, Ou Yingye, Cheng Wenming, Ruwen Lin, Hongzu Li, Zhang Qianli, Xuelu Bei, Weibin Wu, Li Shuo, Xuan Zhang, Huang Weixin, Chunyun Hu, Yao Ma, Jinlong Rao, Jie Yan, Youyou Cai, Ningbin Wu, Wen Xiaoming, Shoujia Liu, Tingting Pan, Gang Liu, Purong Zheng
Publikováno v:
Journal of medicinal chemistry. 61(4)
Salutaxel (3) is a conjugate of docetaxel (7) and a muramyl dipeptide (MDP) analogue. Docetaxel (7) has been recognized as a highly active chemotherapeutic agent against various cancers. MDP and its analogues are powerful potentiators of the antitumo
Autor:
Xiaoming Wen, Purong Zheng, Yao Ma, Yingye Ou, Weixin Huang, Shuo Li, Shoujia Liu, Xuan Zhang, Ziyu Wang, Qianli Zhang, Wenming Cheng, Ruwen Lin, Hongzu Li, Youyou Cai, Chunyun Hu, Ningbin Wu, Long Wan, Tingting Pan, Jinlong Rao, Xuelu Bei
Publikováno v:
Journal of Medicinal Chemistry; 2/22/2018, Vol. 61 Issue 4, p1519-1540, 22p
Autor:
Ningbin Wu, Zhao Wang, Liliana Florea, Jason Qian, Krishna Banaudha, Wenjie Bao, Ajit Kumar, Rakesh Kumar, Laurent Houzet
Publikováno v:
Infectious Agents and Cancer
Background Hepatitis C virus (HCV) infection is a major risk factor for chronic hepatitis and hepatocellular carcinoma (HCC); however, the mechanism of HCV-mediated hepatocarcinogenesis is not well understood. Insufficiency of PTEN tumor suppressor i